These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Expression of extracellular matrix metalloproteases inducer on micrometastatic and primary mammary carcinoma cells. Reimers N; Zafrakas K; Assmann V; Egen C; Riethdorf L; Riethdorf S; Berger J; Ebel S; Jänicke F; Sauter G; Pantel K Clin Cancer Res; 2004 May; 10(10):3422-8. PubMed ID: 15161697 [TBL] [Abstract][Full Text] [Related]
4. Extracellular matrix metalloprotease inducer-expressing head and neck squamous cell carcinoma cells promote fibroblast-mediated type I collagen degradation in vitro. Rosenthal EL; Zhang W; Talbert M; Raisch KP; Peters GE Mol Cancer Res; 2005 Apr; 3(4):195-202. PubMed ID: 15831673 [TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of extracellular matrix metalloprotease inducer: immunohistochemical analyses of colorectal tumors and immunocytochemical screening of disseminated tumor cells in bone marrow from patients with gastrointestinal cancer. Buergy D; Fuchs T; Kambakamba P; Mudduluru G; Maurer G; Post S; Tang Y; Nakada MT; Yan L; Allgayer H Cancer; 2009 Oct; 115(20):4667-78. PubMed ID: 19569245 [TBL] [Abstract][Full Text] [Related]
6. EMMPRIN expression in tongue squamous cell carcinoma. Huang Z; Huang H; Li H; Chen W; Pan C J Oral Pathol Med; 2009 Jul; 38(6):518-23. PubMed ID: 19473445 [TBL] [Abstract][Full Text] [Related]
7. Expression and clinical significance of CD147 in genitourinary carcinomas. Han ZD; He HC; Bi XC; Qin WJ; Dai QS; Zou J; Ye YK; Liang YX; Zeng GH; Zhu G; Chen ZN; Zhong WD J Surg Res; 2010 May; 160(2):260-7. PubMed ID: 19286191 [TBL] [Abstract][Full Text] [Related]
8. Emmprin, a cell surface inducer of matrix metalloproteinases (MMPs), is expressed in T-cell lymphomas. Nabeshima K; Suzumiya J; Nagano M; Ohshima K; Toole BP; Tamura K; Iwasaki H; Kikuchi M J Pathol; 2004 Mar; 202(3):341-51. PubMed ID: 14991900 [TBL] [Abstract][Full Text] [Related]
9. Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases. Tang Y; Nakada MT; Kesavan P; McCabe F; Millar H; Rafferty P; Bugelski P; Yan L Cancer Res; 2005 Apr; 65(8):3193-9. PubMed ID: 15833850 [TBL] [Abstract][Full Text] [Related]
10. EMMPRIN expression as a prognostic factor in radiotherapy of cervical cancer. Ju XZ; Yang JM; Zhou XY; Li ZT; Wu XH Clin Cancer Res; 2008 Jan; 14(2):494-501. PubMed ID: 18223224 [TBL] [Abstract][Full Text] [Related]
11. Increasing expression of extracellular matrix metalloprotease inducer in renal cell carcinoma: tissue microarray analysis of immunostaining score with clinicopathological parameters. Jin JS; Hsieh DS; Lin YF; Wang JY; Sheu LF; Lee WH Int J Urol; 2006 May; 13(5):573-80. PubMed ID: 16771728 [TBL] [Abstract][Full Text] [Related]
12. Identification of an active site of EMMPRIN for the augmentation of matrix metalloproteinase-1 and -3 expression in a co-culture of human uterine cervical carcinoma cells and fibroblasts. Sato T; Ota T; Watanabe M; Imada K; Nomizu M; Ito A Gynecol Oncol; 2009 Aug; 114(2):337-42. PubMed ID: 19427027 [TBL] [Abstract][Full Text] [Related]
13. Expression of extracellular matrix metalloproteinase inducer and enhancement of the production of matrix metalloproteinase-1 in tongue squamous cell carcinoma. Cao Z; Xiang J; Li C Int J Oral Maxillofac Surg; 2009 Aug; 38(8):880-5. PubMed ID: 19372030 [TBL] [Abstract][Full Text] [Related]
14. Tumor-stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-dependent generation of soluble EMMPRIN. Tang Y; Kesavan P; Nakada MT; Yan L Mol Cancer Res; 2004 Feb; 2(2):73-80. PubMed ID: 14985463 [TBL] [Abstract][Full Text] [Related]
15. Increasing expression of extracellular matrix metalloprotease inducer in ovary tumors: tissue microarray analysis of immunostaining score with clinicopathological parameters. Jin JS; Yao CW; Loh SH; Cheng MF; Hsieh DS; Bai CY Int J Gynecol Pathol; 2006 Apr; 25(2):140-6. PubMed ID: 16633062 [TBL] [Abstract][Full Text] [Related]
16. EMMPRIN modulates migration and deposition of TN-C in oral squamous carcinoma. Dang D; Atakilit A; Ramos DM Anticancer Res; 2008; 28(4B):2049-54. PubMed ID: 18751374 [TBL] [Abstract][Full Text] [Related]
17. High incidence of extracellular matrix metalloproteinase inducer expression in non-small cell lung cancers. Association with clinicopathological parameters. Hakuma N; Betsuyaku T; Kinoshita I; Itoh T; Kaga K; Kondo S; Nishimura M; Dosaka-Akita H Oncology; 2007; 72(3-4):197-204. PubMed ID: 18160808 [TBL] [Abstract][Full Text] [Related]
18. Modulation of tumor cell growth in vivo by extracellular matrix metalloprotease inducer. Newman JR; Bohannon IA; Zhang W; Skipper JB; Grizzle WE; Rosenthal EL Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1218-24. PubMed ID: 19015455 [TBL] [Abstract][Full Text] [Related]
19. Basigin (murine EMMPRIN) stimulates matrix metalloproteinase production by fibroblasts. Li R; Huang L; Guo H; Toole BP J Cell Physiol; 2001 Mar; 186(3):371-9. PubMed ID: 11169976 [TBL] [Abstract][Full Text] [Related]
20. [The effect of the microenvironment of head and neck cancers on tumor progression]. Lukits J Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]